Torrent Pharmaceuticals has received a demand notice from the National Pharmaceutical Pricing Authority (NPPA) concerning alleged overcharging for two drugs. The notice, issued on September 24, 2025, alleges overcharging during the period from May 2018 to July 2020 and August 2023. The company has assessed the situation and determined that the notice will not have a material impact on its financials or operations.
Demand Notice Details
Torrent Pharmaceuticals has been notified by the National Pharmaceutical Pricing Authority (NPPA) regarding potential overcharging on two of its drug products. The demand notice was officially issued on September 24, 2025 and received by the company on September 29, 2025.
Alleged Overcharging Period
The demand notice specifically addresses allegations of overcharging for two drugs. The alleged periods of overcharge are May 2018 to July 2020, and also the month of August 2023. The amount in question is a penalty of ₹ 60,28,721/-
Impact Assessment
Following an internal assessment, Torrent Pharmaceuticals has stated that the receipt of this demand notice will not have a material impact on the company’s financial standing or its day-to-day operations.
Source: BSE
